Withdrawal symptoms from phenytoin, carbamazepine and sodium valproate
- PMID: 3144581
- PMCID: PMC1033195
- DOI: 10.1136/jnnp.51.7.924
Withdrawal symptoms from phenytoin, carbamazepine and sodium valproate
Abstract
A prospective, double-blind, placebo-controlled investigation of possible withdrawal symptoms from phenytoin, carbamazepine and sodium valproate is reported in patients with active epilepsy, on combination therapy. There was an increase in seizures on reduction and withdrawal of carbamazepine, but there was no convincing evidence of withdrawal symptoms from any of these drugs.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical